387 related articles for article (PubMed ID: 17425490)
1. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
Staller JA; Faraone SV
Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
[TBL] [Abstract][Full Text] [Related]
2. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
Denney CB
J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
[TBL] [Abstract][Full Text] [Related]
3. Attention deficit and hyperactivity disorder: review of genetic association studies.
Galili-Weisstub E; Segman RH
Isr J Psychiatry Relat Sci; 2003; 40(1):57-66. PubMed ID: 12817670
[TBL] [Abstract][Full Text] [Related]
4. A review of the biological bases of ADHD: what have we learned from imaging studies?
Durston S
Ment Retard Dev Disabil Res Rev; 2003; 9(3):184-95. PubMed ID: 12953298
[TBL] [Abstract][Full Text] [Related]
5. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
Arnsten AF
J Clin Psychiatry; 2006; 67 Suppl 8():7-12. PubMed ID: 16961424
[TBL] [Abstract][Full Text] [Related]
6. Drug policy and treatment bias due to the dopamine-deficit theory of child attention-deficit hyperactivity disorder.
Rastmanesh R
Atten Defic Hyperact Disord; 2010 Nov; 2(3):149-57. PubMed ID: 21432601
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
Prince J
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
[TBL] [Abstract][Full Text] [Related]
8. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
Genro JP; Kieling C; Rohde LA; Hutz MH
Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210
[TBL] [Abstract][Full Text] [Related]
9. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Fowler JS; Ding YS
Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
[TBL] [Abstract][Full Text] [Related]
10. Study supports medication for ADHD.
Health News; 2000 Feb; 6(2):5. PubMed ID: 10734823
[No Abstract] [Full Text] [Related]
11. The stimulants revisited.
Wilens TE; Spencer TJ
Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):573-603, viii. PubMed ID: 10944658
[TBL] [Abstract][Full Text] [Related]
12. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
[TBL] [Abstract][Full Text] [Related]
13. Attention deficit hyperactivity disorder in sport: a review.
Corrigan B
Int J Sports Med; 2003 Oct; 24(7):535-40. PubMed ID: 12968213
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychiatry; 2006; 67 Suppl 8():32-8. PubMed ID: 16961428
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
Wilens TE
J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study.
Ludolph AG; Kassubek J; Schmeck K; Glaser C; Wunderlich A; Buck AK; Reske SN; Fegert JM; Mottaghy FM
Neuroimage; 2008 Jul; 41(3):718-27. PubMed ID: 18424180
[TBL] [Abstract][Full Text] [Related]
17. [Current evidence about atomoxetine. A therapeutic alternative for the treatment of attention deficit hyperactivity disorder].
Velásquez-Tirado JD; Peña JA
Rev Neurol; 2005 Oct 16-31; 41(8):493-500. PubMed ID: 16224736
[TBL] [Abstract][Full Text] [Related]
18. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
van der Kooij MA; Glennon JC
Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
[TBL] [Abstract][Full Text] [Related]
19. Attention-deficit/hyperactivity disorder endophenotypes.
Doyle AE; Willcutt EG; Seidman LJ; Biederman J; Chouinard VA; Silva J; Faraone SV
Biol Psychiatry; 2005 Jun; 57(11):1324-35. PubMed ID: 15950005
[TBL] [Abstract][Full Text] [Related]
20. [Neurobiology of attention deficit/hyperactivity disorder].
Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
